Tevogen Statistics
NASDAQ: TVGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
5.90-0.40 (-6.35%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Tevogen by the numbers
Tevogen has a market capitalization of $405.2 million based on 68.68M shares outstanding. With trailing EPS of $-7.01, Tevogen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.7% below its 50-day average and 20.7% below its 200-day average.
Average daily trading volume is 7.94K shares, or about $46,864 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TVGN valuation vs. peer median
| Metric | TVGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $405.20M | $423.78M | -4% |
| Avg. volume | 7.94K | 1.33M | -99% |
Peer median across 8 companies: TECX, CADL, PROK, IRLA, FENC, ALEC, RGNX, SANA.
Valuation
- Market cap
- $405.20M
- EPS (TTM)
- $-7.01
- Shares outstanding
- 68.68M
Price and trading
- Previous close
- 6.30
- Open
- 6.35
- Day range
- 5.72 – 6.35
- 52-week range
- 3.64 – 24.90
- 52-week change
- -73.84%
- Beta
- —
- Volume
- 9.35K
- Average volume
- 7.94K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 405.20M
- Eps
- -7.01
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 24.90
- Week52 Low
- 3.64
- Avg Volume
- 7,943.00
- Shares Outstanding
- 68.68M
- Ma50
- 6.61
- Ma200
- 7.44
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -76.31%
- Pct From52w Low
- 62.27%